Drug Type Small molecule drug |
Synonyms Benidipine hydrochloride (JP17), 贝尼地平, KW 3049 + [7] |
Target |
Mechanism Cav2.1 inhibitors(calcium voltage-gated channel subunit alpha1 A inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (04 Oct 1991), |
Regulation- |
Molecular FormulaC28H32ClN3O6 |
InChIKeyKILKDKRQBYMKQX-QABSGUMLSA-N |
CAS Registry91599-74-5 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02045 | Benidipine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | CN | 29 Jan 2003 | |
Parenchymal renal hypertension | JP | 01 Jun 1994 | |
Angina Pectoris | JP | 04 Oct 1991 |
Phase 4 | 3,501 | Benidipine + Thiazide | euwbxdoeen(aabyvgjmnj) = qwrpdmzafk ufefdtrghq (uotvyexynh ) View more | - | 29 Jan 2020 | ||
Benidipine + β-blocker | euwbxdoeen(aabyvgjmnj) = qucvcbkany ufefdtrghq (uotvyexynh ) View more |